CSPC Pharmaceutical Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
6,145.00
8,225.00
8,835.00
8,225.00
7,166.00
5,179.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-886.00
-3,350.00
928.00
-1,672.00
1,888.00
-549.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
5,195.00
4,924.00
9,225.00
5,862.00
7,674.00
4,392.00
Cash Flow from Investing Activities
-4,692.00
924.00
-8,188.00
-1,058.00
-2,599.00
-2,870.00
Cash Flow from Financing Activities
-5,438.00
-3,160.00
-2,222.00
-2,646.00
-1,650.00
-1,769.00
Net Cash Inflow / Outflow
-4,931.00
2,693.00
-1,169.00
2,154.00
3,421.00
-246.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
3.00
5.00
16.00
-2.00
-2.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CSPC Pharmaceutical Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
6145.59758410827
5241.56957575554
904.00
17.25%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-886.096030200254
-867.925522820134
-19.00
-2.09%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
5195.84026677128
5813.10082675025
-618.00
-10.62%
Cash Flow from Investing Activities
-4692.30936672872
-5852.07216854523
1,160.00
19.82%
Cash Flow from Financing Activities
-5438.2922339854
-1559.8685053157
-3,879.00
-248.64%
Net Cash Inflow / Outflow
-4931.07605710216
-1507.78347614563
-3,424.00
-227.04%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
3.68527684068735
91.0563709650462
-88.00
-95.95%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 5.52% vs -46.62% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
5,195.84
4,924.25
5.52%






